|
|
Substance Name: Tritoqualine [INN:DCF]
RN: 14504-73-5
UNII: F4MW5166YH
InChIKey: IRGJVQIJENCTQF-UHFFFAOYSA-N
Classification Codes
- Drug / Therapeutic Agent
- Histamine Agents
- Histamine Antagonists
- Histamine H1 Antagonists
- Neurotransmitter Agents
Molecular Formula
- C26-H32-N2-O8
Molecular Weight
- 500.5448
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Tritoqualine
- Tritoqualine [INN:DCF]
Synonyms
- 35NZ
- 4,5,6-Triethoxy-7-amino-3-(8-methoxy-2-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydro-1-isochinolinyl)phthalid
- 554L
- 7-Amino-4,5,6-triethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)phthalide
- BRN 0634993
- Hypostamin
- Hypostamine
- Inhibostamin
- L 554
- L-554
- MCI-5011
- Tritocualina
- Tritocualina [INN-Spanish]
- Tritocualina [Spanish]
- Tritoqualine
- Tritoqualinum
- Tritoqualinum [INN-Latin]
- UNII-F4MW5166YH
Systematic Names
- 1(3H)-Isobenzofuranone, 7-amino-4,5,6-triethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-
- 7-Amino-4,5,6-triethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-1(3H)-isobenzofuranone
- 7-Amino-4,5,6-triethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)phthalide
Registry Numbers
CAS Registry Number
- 14504-73-5
FDA UNII
- F4MW5166YH
Other Registry Numbers
- 20438-00-0
- 4835-67-0
- 6429-02-3
System Generated Number
- 0014504735
Structure Descriptors
InChI
InChI=1S/C26H32N2O8/c1-6-31-23-17-16(18(27)24(32-7-2)25(23)33-8-3)26(29)36-21(17)19-15-13(9-10-28(19)4)11-14-20(22(15)30-5)35-12-34-14/h11,19,21H,6-10,12,27H2,1-5H3InChIKey
IRGJVQIJENCTQF-UHFFFAOYSA-NSmiles
CCOc1c(N)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | > 15gm/kg (15000mg/kg) | GASTROINTESTINAL: DECREASED MOTILITY OR CONSTIPATION SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 1129, 1986. |
mouse | LD50 | oral | > 15gm/kg (15000mg/kg) | KIDNEY, URETER, AND BLADDER: OTHER CHANGES AUTONOMIC NERVOUS SYSTEM: "SMOOTH MUSCLE RELAXANT (MECHANISM UNDEFINED, SPASMOLYTIC)" | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 1129, 1986. |
mouse | LD50 | subcutaneous | > 15gm/kg (15000mg/kg) | BLOOD: CHANGES IN SPLEEN SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 1129, 1986. |
rat | LD50 | intraperitoneal | > 15gm/kg (15000mg/kg) | GASTROINTESTINAL: DECREASED MOTILITY OR CONSTIPATION SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 1129, 1986. |
rat | LD50 | oral | > 15gm/kg (15000mg/kg) | KIDNEY, URETER, AND BLADDER: OTHER CHANGES AUTONOMIC NERVOUS SYSTEM: "SMOOTH MUSCLE RELAXANT (MECHANISM UNDEFINED, SPASMOLYTIC)" | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 1129, 1986. |
rat | LD50 | subcutaneous | > 15gm/kg (15000mg/kg) | BLOOD: CHANGES IN SPLEEN SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 129, 1986. |